Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04321200 · ClinicalTrials.gov registry record

PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

A clinical trial of Infant Development and Neurodevelopmental Disorders, sponsored by University of Pennsylvania.

Recruiting
Registry status
1,700
Enrollment target
1
Study location

NCT04321200: Recruiting study of Infant Development and Neurodevelopmental Disorders, sponsored by University of Pennsylvania.

NCT04321200 is a study of Infant Development and Neurodevelopmental Disorders that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,700 participants, above the 346-participant average among 30 other Infant Development trials with a reported enrollment target (391% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04321200, a study of Infant Development and Neurodevelopmental Disorders, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
1,700 participants
Enrollment target
1
Study location

Study Summary

Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state of the art sensors combined with machine learning algorithms to develop objective, accurate, easy-to-use tools for the early scoring of deficits and lays the foundation for the early prediction of physical disability.

Primary Outcome

The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.

Interventions

  • DIAGNOSTIC_TEST PANDA Gym
  • OTHER Mobile App

Study Locations (1)

Pennsylvania

  • Childrens Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,700 participants
Start Date 2020-11-01
Est. Completion 2026-07-01
University of Pennsylvania

1,423 total trials

What NCT04321200 shows while recruiting

NCT04321200 is an observational study that tracks outcomes without assigning an intervention. Its 1,700 participants enrollment target places it among the larger protocols in the corpus, above the 346-participant average among 30 other Infant Development trials with a reported enrollment target (391% higher).

The record links to 3 conditions, with Infant Development appearing as the primary indexed condition, and to 2 interventions - of which PANDA Gym is the first listed.

NCT04321200 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04321200 about?

NCT04321200 is a clinical study titled "PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability". Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state of the art sensors combined with machine learning algorithms to develop objective, accurate, easy-to-use tools for the early scoring of defi...

What is the current status of trial NCT04321200?

This trial is currently recruiting. The enrollment target is 1,700 participants. The study started on 2020-11-01. Estimated completion is 2026-07-01.

What conditions does trial NCT04321200 study?

This clinical trial studies the following conditions: Infant Development, Neurodevelopmental Disorders, Pediatric ALL.

What interventions are being tested in trial NCT04321200?

The interventions under investigation include: PANDA Gym (DIAGNOSTIC_TEST), Mobile App (OTHER).

Who is sponsoring clinical trial NCT04321200?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04321200 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04321200's enrollment target sits among peer trials

1,700 3rd of 30 higher than 28 of 30 other Infant Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06238622 · 1,700 participants · Phase 3

    A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  • NCT07284901 · 1,700 participants · Phase 3

    Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • NCT07304531 · 1,705 participants

    First To Know Pregnancy Test - Clinical Evaluation Protocol

  • NCT05303636 · 1,710 participants · Phase 4

    LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04321200, the US trial registry maintained by the National Library of Medicine. NCT04321200 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.